BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 A$
0,00%
(0,00) 1K
18-noy, 16:10:16 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
27,63 mln
Oʻrtacha hajm
10,87 mln
Hajmi
29,97 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
27,63 mln
Oʻrtacha hajm
10,87 mln
Hajmi
29,97 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Invezz
·
39 daqiqa oldin
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
24/7 Wall St.
·
29 daqiqa oldin
S&P 500 Slides 0.6% at Midday as the Dow Drops Over 1%
TradingView
·
1 soat oldin
S&P 500, Nasdaq find footing as Nvidia treads water
JournalArta
·
34 daqiqa oldin
S&P 500 Futures Rise After Nvidia Raises Sales Forecast
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida